Dr Martin J Tobin discusses health disparities related to pulse oximeter accuracy and the need for improvement to make health care equitable.

Understanding how AI-driven bias affects Black patients and knowing how to advocate for equitable healthcare is essential.

As concern grows over racial bias in common medical tools like pulse oximeters, ... The FDA wants to change that. Jan 6, 2025. Pulse oximeter performance varies by skin pigment.

The FDA launched an artificial intelligence tool Monday dubbed Elsa, with Commissioner Marty Makary hyping the effort’s early debut “to modernize how the agency functions.” ...

When Google announced the Pixel Watch 3 last summer, the company promised it would get a life-saving new feature — Loss of ...

Bristol Myers (BMY) receives FDA approval for label updates for Breyanzi and Abecma, that can ease access to the cancer cell ...

The FDA may be facing a 4% cut to its overall budget courtesy of the Trump administration, but that hasn’t stopped the agency from unveiling a new generative AI tool a month ahead of schedule.

The FDA is using Elsa to accelerate clinical protocol reviews, shorten the time needed for scientific evaluations and identify high-priority inspection targets. The Food and Drug Administration ...

The FDA introduced Elsa, an artificial intelligence (AI) tool intended to enhance efficiency in clinical reviews and scientific evaluations. News All News Press Releases Product Approvals and Launches ...

FDA's long-standing accelerated approval program generally issues decisions in six months for drugs that treat life-threatening diseases. Regular drug reviews take about 10 months.

Four Democrat-led states ask FDA to remove abortion pill restrictions. The attorneys general of New York, California, Massachusetts and New Jersey asked the FDA to lift some requirements on ...